BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25135278)

  • 1. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling.
    Hu S; Li L; Yeh S; Cui Y; Li X; Chang HC; Jin J; Chang C
    Mol Oncol; 2015 Jan; 9(1):44-57. PubMed ID: 25135278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals.
    Xie H; Li L; Zhu G; Dang Q; Ma Z; He D; Chang L; Song W; Chang HC; Krolewski JJ; Nastiuk KL; Yeh S; Chang C
    Oncotarget; 2015 May; 6(14):12326-39. PubMed ID: 25940439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.
    Li L; Dang Q; Xie H; Yang Z; He D; Liang L; Song W; Yeh S; Chang C
    Oncotarget; 2015 Jun; 6(16):14179-90. PubMed ID: 25895025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.
    Deng G; Wang R; Sun Y; Huang CP; Yeh S; You B; Feng C; Li G; Ma S; Chang C
    Cell Death Differ; 2021 Jul; 28(7):2145-2159. PubMed ID: 34127806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals.
    Dang Q; Li L; Xie H; He D; Chen J; Song W; Chang LS; Chang HC; Yeh S; Chang C
    Mol Oncol; 2015 Aug; 9(7):1241-51. PubMed ID: 25817444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals.
    Ou Z; Wang Y; Liu L; Li L; Yeh S; Qi L; Chang C
    Oncotarget; 2015 Sep; 6(28):26065-78. PubMed ID: 26305549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis.
    Lin TH; Lee SO; Niu Y; Xu D; Liang L; Li L; Yeh SD; Fujimoto N; Yeh S; Chang C
    J Biol Chem; 2013 Jul; 288(27):19359-69. PubMed ID: 23687298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
    Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
    Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals.
    Luo J; Lee SO; Cui Y; Yang R; Li L; Chang C
    Oncotarget; 2015 Sep; 6(29):27555-65. PubMed ID: 26342197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer.
    Larsson P; Syed Khaja AS; Semenas J; Wang T; Sarwar M; Dizeyi N; Simoulis A; Hedblom A; Wai SN; Ødum N; Persson JL
    Int J Cancer; 2020 Mar; 146(6):1686-1699. PubMed ID: 31381135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals.
    Tao L; Qiu J; Jiang M; Song W; Yeh S; Yu H; Zang L; Xia S; Chang C
    Mol Cancer Ther; 2016 Aug; 15(8):1943-1951. PubMed ID: 27196763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
    Chen Y; Sun Y; Rao Q; Xu H; Li L; Chang C
    Oncotarget; 2015 Oct; 6(31):31203-15. PubMed ID: 26304926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals.
    Wang X; Lee SO; Xia S; Jiang Q; Luo J; Li L; Yeh S; Chang C
    Mol Cancer Ther; 2013 Jun; 12(6):1026-37. PubMed ID: 23536722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
    Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
    PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
    Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
    Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
    Mandel A; Larsson P; Sarwar M; Semenas J; Syed Khaja AS; Persson JL
    Mol Med; 2018 Jun; 24(1):34. PubMed ID: 30134822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.
    Izumi K; Fang LY; Mizokami A; Namiki M; Li L; Lin WJ; Chang C
    EMBO Mol Med; 2013 Sep; 5(9):1383-401. PubMed ID: 23982944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.
    Yang Z; Chen J; Xie H; Liu T; Chen Y; Ma Z; Pei X; Yang W; Li L
    Cancer Lett; 2020 Mar; 473():118-129. PubMed ID: 31843555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
    Yue D; Wang Y; Sun Y; Niu Y; Chang C
    Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASC-J9
    Lin W; Luo J; Sun Y; Lin C; Li G; Niu Y; Chang C
    Cancer Lett; 2018 Jul; 425():21-30. PubMed ID: 29425687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.